Delhi Pharmaceutical Sciences and Research University (The first university dedicated to the pharmaceutical sciences in India)  Vision To be the ultimate destination for education, training and research in pharmaceutical sciences and allied areas and thereby, cater the health needs of the people at large.

Post : Assistant Registrar

National Institute of Biologicals (NIB) had been set up in 1992 as an apex autonomous Institute under the administrative control of the Ministry of Health & Family Welfare, Government of India for promoting and protecting human health through various activities assigned to it.  The mandate of the Institute includes ensuring provision of quality biological drugs i.e Invitro diagnostics, Vaccines and Biotherapeutics, including therapeutic monoclonal antibodies used by patients suffering from cancer and autoimmune diseases by undertaking high end science based testing with R&D interface for application of science.

Post : Director

The U.S. Pharmacopeial Convention (USP) is a scientific non-profit organization that sets standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements manufactured, distributed and consumed worldwide. USP’s drug standards are enforceable in the United States by the Food and Drug Administration, and these standards are used in more than 140 countries.

Post : Scientist III

S.P College of Pharmaceutical Science & Research - The Premier Educational Institute, situated at bijnor Road, Chandpur, Bijnor, for imparting different Courses having well equipped library, laboratories & other amenities. S.P College of Pharmaceutical Science & Research is run by qualified and experienced professionals. S.P College of Pharmaceutical Science & Research offers special fee concession and scholarship to the meritorious and deserving candidates. S.P College of Pharmaceutical Science & Research has been governed by S.P Educational Society, being managed by very dynamic and renowned personalities in the field of education.

Post : Assistant professor, Associate professor, professor, lecturers

Oracity Life Sciences was focusing on solid oral dosage forms (Tablets / capsules) with immediate as well as modified release technology. We will be catering Granules for immediate release, modified release tablets, different range of pellets formulation ready to encapsulate, MUPS ready to compress along with finished dose formulation of tablets and capsules. We have designed the facility / systems to meet all regulatory standards (like WHO, MHRA, USFDA etc…) and will be catering to domestic, ROW and highly regulated market.

Post : Regulatory Affair Executive - 03 posts

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation. Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

Hetero Healthcare is a Pharmaceutical Manufacturing Company with its head quartered at Hyderabad. We catered to different product of various therapeutic groups. We aim to improve the quality life of the people with our product line and along with a continuous Research and Development process. Hetero Health Care team uses all its experience which it has gained from over a century to add its benefits for the development of human life span.

Unison Pharmaceuticals Private Limited (Formerly known as Unison Pharmaceuticals) was established in 1981 with a vision of providing quality & most affordable medicines across the nation. With more than 3 decades of medical service to the society, Unison is today one of the fastest growing company in Gujarat State. The base of operation being a single state, the company has very strong footing in the market. The company strictly believes in ethics and moral values throughout the operations of the business.

HSN is a healthcare company in Haridwar, Uttarakhand (India), established and formed in the year 2007. HSN has established an ultra modern facility as per cGMP standards to manufacture tablets, oral liquid and ointment. HSN International has come up with new unit, HSN Biotech- it is a manufacturing entity having huge capacity to manufacture million of tablets and oral liquids per day. The firm is committed to promoting healthcare.

COMPANY STARTED IN 2017 IN PHARMA GLOBAL INDUSTRY.WE HANDLED OPERATION IN UTTAR PRADESH AND MADHYA PRADESH.

Post : Field Sales Officer

Dano Vaccines and Biologicals Private Limited is one of the experienced manufacturer of Tetanus Toxoid (T.T) Vaccine since 1985. Dano is involved in manufacturing and distribution of Tetanus Toxoid (T.T) Vaccine for the past 36 years. Our mission is to provide quality and affordable life-saving vaccines.

Biogen pharmaceutical co’s services continue to care from prevention and cure. Biogen pharmaceutical co is devoted to the Innovation, manufacture, co-market and export of Pharmaceuticals and hospital products for Human. Biogen pharmaceutical co will ensures its presence in Indian markets for its products and services to companies with marketing alliance. Biogen pharmaceutical co today, has a strong reputation in marketing to the healthcare solutions.

Central Council for Research in Homoeopathy (CCRH) is an apex research organization under Ministry of AYUSH, Govt. of India which undertakes, coordinates, develops, disseminates and promotes scientific research in Homoeopathy.   The Headquarters of the Council are situated in New Delhi and multi-centric research is conducted through a network of 26 institutes/units all over India.

Post : Research Associate (Pharmacology)

The Regional Research Centre of Ayurveda (RRCA), Port Blair previously known as Ayurveda Tribal Health Care Research Project [ATHCRP] was established in the year 1984 at Malacca, Car Nicobar of A&N Islands. Unfortunately, this Research Centre along with all the records had submerged in the sea during the Earthquake and Tsunami on 26th December 2004. Thereafter this project was shifted from Car Nicobar to 30 bedded AYUSH Hospital, Atlanta Point, Port Blair on 14th February 2005 and henceforth it functioned there up to January 2015.

Post : Pharmacist (Ayurveda) - 01 Post

Torrent Pharma, the flagship Company of Torrent Group is one of the leading pharma companies of the Country. The Company was a pioneer in initiating the concept of niche marketing in India and and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC).

Troikaa Pharma is a leading company with the remarkable ability to constantly innovate through creative Imagination. Our NDDS brands Dynapar AQ and Dynapar QPS are path breaking & have revolutionised pain care. These innovative products are backed by strong global patents. Continuous focus on innovation and an unwavering commitment to quality has helped Troikaa establish itself both in domestic and international markets.

Aalidhra Pharmachem is an (ISO 9001, 14001, OHSAS 18001 and Schedule M certified) Pharmaceutical Intermediates AND API manufacturing company established in 2015. We are working very closely with our customers to develop API opportunities to provide alternative, more economical, second-source options for existing generic drugs. By leveraging our worldwide sourcing, regulatory and quality assurance capabilities, we provide to generic drug manufacturers an alternative, economical source for existing API products. We, at Aalidhra Pharmachem Pvt. Ltd.

The 11th Annual Clinical Trials Summit 2020 to be held in Mumbai, India during 28th May 2020. The global Contract Research Organization (CRO) market size was estimated at US$ 34.5 billion in 2018 and is projected to reach US$ 55.3 billion by 2024, growing at a CAGR of 8.2% during 2019 to 2024. Indian clinical trials market size is expected to reach US$ 3.15 billion by 2025. It is projected to register a CAGR of 8.7% over the forecast period.Increasing cost of drug development is expected to drive the growth. Drug maker and sponsor companies are under pressure to replace the revenue loss caused by generics, increasing patent expiry, number of partnerships to identify biologics, and growing R&D costs, which has made drug development more expensive and complex. In addition, growing pressure on market players to follow stringent timelines has increased the demand for outsourcing of research activities.This Conference brings together Researchers, Doctors, Principle Investigators, Clinical research sites, CROs, CMOs, Investors, and senior executives from Biopharma, Medical devices and Pharmaceutical industries around the globe to discuss, reflect on and develop their ideas.